3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
32
Lymphoid
15
Other hematologic neoplasm
7
Thoracic
5
Sarcoma
4
Gastrointestinal
3
Genitourinary
2
Plasma cell
1
Dermatologic
1
CNS
1
Conditions
Prostatic Neoplasms
2966
Carcinoma, Renal Cell
882
Urinary Bladder Neoplasms
711
Kidney Neoplasms
457
Breast Neoplasms
408
Neoplasms
390
Neoplasm Metastasis
229
Carcinoma, Non-Small-Cell Lung
229
Lung Neoplasms
216
Ovarian Neoplasms
211
Colorectal Neoplasms
204
Melanoma
195
Carcinoma, Transitional Cell
190
Testicular Neoplasms
171
Pancreatic Neoplasms
142
Sarcoma
129
Head and Neck Neoplasms
121
Colonic Neoplasms
120
Wilms Tumor
119
Uterine Cervical Neoplasms
116
Stomach Neoplasms
98
Neuroblastoma
90
Multiple Myeloma
88
Lymphoma, Non-Hodgkin
86
Esophageal Neoplasms
86
Lymphoma
83
Carcinoma, Hepatocellular
81
Carcinoma, Ovarian Epithelial
80
Recurrence
75
Squamous Cell Carcinoma of Head and Neck
74
Interventions
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Genitourinary
×
Clear all
NCT01014065
2016-02-25
SUPER
AHS Cancer Control Alberta
Completed
42 enrolled
NCT01095926
2013-06-28
Doxo
University Hospital Muenster
Phase 2
Completed
101 enrolled